https://doi.org/10.14475/kjhpc.2018.21.1.23 comparable or higher symptom burdens (i.e., shortness of breath, fatigue, pain, depression, and anxiety) (6,9-11) and poor QOL (11, 12) compared to patients with any other advanced chronic illness.
Palliative care is well-recognized as an optimal comprehensive approach for critically ill patients, particularly during EOL (12) (13) (14) . It has been shown that a hospital-based palliative care service leads to positive patient satisfaction, fewer hospital admissions and in-hospital deaths, less invasive EOL treatments, or fewer hospital expenditures, all of which in turn promote quality of life (13) (14) (15) (16) (17) (18) (19) . The physical and psychological needs of COPD patients during EOL are equivalent or exceed those experienced by patients with other chronic illnesses (8, (20) (21) (22) . Nevertheless, palliative care for COPD patients has received relatively little attention (23) (24) (25) (26) . When compared with patients with cancer or other severe chronic diseases, end-stage COPD patients were less likely to be referred for a palliative consultation (16) . COPD patients are more likely than patients with other chronic illnesses to receive a disproportionate amount of life-sustaining treatment (LST) including intensive procedures (8, 27) and ICU admissions (28) .
Previous studies of patients with chronic illnesses (8, 28, 29) provide valuable information regarding site of death, intensive care admissions, and use of LSTs. There has also been an increase in the use of palliative care programs for major diagnoses in U.S. hospitals (30) . Rush et al. (16) 
METHODS

Data source
This study is a serial, cross-sectional data analysis. We met all of the requirements without explicitly stating the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (31) . We used the NIS database which is a product of the Healthcare Cost and Utilization Project (HCUP) and is sponsored by the Agency for Healthcare Research and Quality (AHRQ) (32) . The NIS database is the largest publicly available all-payer inpatient database in the U.S. and includes data from over 7 million hospital inpatient stays each year. The NIS represents a 20% sample of all nonfederal, short-term hospitals from 44 states in the U.S. and is therefore capable of estimating the delivery of approximately 96% of all hospital inpatient stays in 2014 (33) . The NIS represents the care delivered at more than 4,000 hospitals. It also contains random samples of hospitalizations classified by HCUP member hospitals and stratified by location, teaching status, and bed-size as indicated on the American Hospital Association Annual Survey of Hospitals (34) . Each year, NIS data reflects new hospitalizations from these HCUP member hospitals. The analysis of the NIS uses completely de-identified data with no risk of confidentiality loss. We completed a data user agreement with the AHRQ prior to using the NIS database. Since the data were from a completely de-identified dataset, an institutional review board approval was waived from University of Nevada Las Vegas.
Patient cohort selection
The 2005~2014 NIS datasets were used for analysis. We applied survey weights and adjustment to provide annual national population estimates. Our population of interest was patients ages 18 or older who died during their hospitalization. Patients were identified as having COPD as principal diagnosis, LSTs (systemic procedures, local procedures, surgeries), and palliative care by using ICD-9-CM codes for COPD (Table 1) www.kjhpc.org
Variables of interest
The main outcomes were the proportion of patients with Hospital costs were then adjusted for the annual inflation rate using CMS estimates and were expressed as annual means with 95% confidence intervals (CIs) in 2014 U.S. dollars (35) . compared baseline characteristics. We multiply imputed missing hospital cost using regression analysis models. There were no statistical differences among baseline characteristics between analyzed and missing data. The model was determined to be stable and the assumption of randomly missing data was found to be reasonable using the observed data. All analyses were performed using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC). All reported P-values were 2-tailed and P-value ＜0.05 was considered statistically significant. Figure 1 . Table 2 presents a descriptive analysis of patient and hospital characteristics. More than half of patients received systemic procedures (52.05%), while less than one in ten patients received local procedures (7.87%) or surgeries (3.68%);
RESULTS
Descriptive statistics
29.95% received palliative care. 
Temporal trends statistics
Log-transformed multivariate regression analysis of hospital cost
Exploratory analyses
DISCUSSION
To the best of our knowledge, the current study reports the first ten-year national temporal trends of LSTs, palliative care, is predictable, the disease trajectories for chronic advanced non-cancer disease, such as COPD, are heterogeneous which makes it difficult to accurately assess prognosis (23, 27, 34, 40) and introduce palliative care appropriately. In contrast, other systemic procedures such as blood transfusion and nutrition decreased over time. These findings are consistent with recent reports identifying that restrictive red cell transfusion is not inferior to liberal transfusion except for heart disease (41) and that percutaneous gastrostomy tube feeding might not improve survival or aspiration pneumonia risks when compared to conservative approaches such as nasogastric tube feeding (42) . Hospital cost increases over time in our analysis. We apply higher inflation rate using the CMS' measurement of hospital care compared to the inflation rate using the Consumer Price Index (CPI) for medical care available from the U.S. Bureau of Labor Statistics (49) . We observe the cost-saving effect of palliative care as seen in previous cost analysis studies (15, 18, 50 ), but we add the findings of a cost-increase effect of LSTs. The magnitude of cost-increases from LSTs (systematic procedures 59.0%; local procedures 72.0%; surgeries 55.2%) exceeded the cost-saving effect of palliative care (-28.7%); therefore, annual hospital cost increased by 5.81% in our study.
We find health insurance effects on different health outcomes.
Medicaid patients are sicker than private insurance patients.
There is a disparity of LSTs and palliative care utilization between private insurance and Medicaid patients. Medicaid patients receive more LSTs and less palliative care compared to private insurance patients. We speculate that Medicaid COPD patients not only receive less preventive care before hospital admission but also discuss ACP less frequently compared to private insurance patients.
We acknowledge several limitations. We relied on ICD-9-CM codes that may have limited accuracy in capturing procedures and palliative care due to incorrect or missing data. 
